RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Oxford Science Enterprises
O

Oxford Science Enterprises portfolio

Oxford Science Enterprises has 18 portfolio companies on record at Recent Funding, with 11 investments in the last 12 months.

Type: Venture studio.
Portfolio on Recent Funding: 18.
Deals, last 12 months: 11.
Rounds led: 4 of 27.
Capital in their rounds: $2.13B.
Latest deal: Oyster Therapeutics · Nov 10, 2026.
About this page

It is a venture studio based in Oxford, GB, founded in 2015. It led 4 of the 27 rounds it joined. Its most recent investment on record is Oyster Therapeutics's $60M Series A round in November 2026, alongside Global Brain Corporation, 4BIO Capital, Eli Lilly and 5 others. By category, its portfolio leans toward Health and bio (10) and Manufacturing and industrial (6). It has co-invested with University of Oxford, Syncona Partners LLP and GV, most often University of Oxford (6 rounds).

About Oxford Science Enterprises

Firm type: Venture studio.
Headquarters: Oxford, GB.
Founded: 2015.
Stages: Pre-Seed, Seed, Series A, Series B, Series C, Growth.
Sectors: AgTech, AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Healthtech, Medical Devices, Quantum Computing, Robotics, Sector Agnostic.
Check size: $63.5K to $31.75M.
Leads rounds: Yes.
Portfolio companies: 91.
Exits: 1.
Rounds led: 7.

What Oxford Science Enterprises invests in

Oxford Science Enterprises recent investments

How Oxford Science Enterprises invests

StageDealsCapital in rounds
Series A 13 48%$651.61M
Series B+ 12 44%$1.46B
Seed 2 7%$16.5M
YearDealsCapital in rounds
2018 1 4%$13M
2020 3 11%$19.71M
2021 1 4%$33M
2022 4 15%$233.5M
2023 3 11%$199.5M
2024 2 7%$150M
2025 2 7%$85M
2026 11 41%$1.39B

Oxford Science Enterprises portfolio companies

CompanyRound with Oxford Science EnterprisesTotal raisedLatest raise
OOyster Therapeutics
Health and bio
Series A · $60M$60MNov 10, 2026
Series A
AAlethio Therapeutics
Health and bio
Series A · $90M$90MNov 5, 2026
Series A
FFluoRok
Health and bio
Series A · $29.9M$29.9MNov 5, 2026
Series A
OOMass Therapeutics
Health and bio
Series B+ · $310M$422.51MOct 15, 2026
Series B+
SSalience Labs
AI infrastructure and compute
Series B+ · $125M$166.5MOct 14, 2026
Series B+
SSensible Biotechnologies
Health and bio
Series A · $47M · lead$51.2MOct 6, 2026
Series A
MMCatalysis
Robotics and hardware
Seed · $5M · lead$5MSep 9, 2026
Seed
AAmber Therapeutics
Health and bio
Series A · $100M$200MJul 24, 2026
Series A
RRQ Bio
Health and bio
Series A · $115M$115MJun 24, 2026
Series A
OOxford Quantum Circuits
AI infrastructure and compute
Series B+ · $350M$497MJun 2, 2026
Series B+
QQuantum Motion
Robotics and hardware
Series B+ · $160M$220.21MMay 7, 2026
Series B+
UUltromics
Health and bio
Series B+ · $55M$111MAug 11, 2025
Series B+
GGrey Wolf Therapeutics
Health and bio
Series B+ · $50M$99MMay 23, 2024
Series B+
OONI
Health and bio
Series B+ · $75M$75MJan 29, 2022
Series B+
BBibli U
Data and analytics
Series A · $10M$80.65MJun 2, 2026
round
QQuantrolOx
Data and analytics
backer$13.45MOct 22, 2026
Series A
OOpsydia
Robotics and hardware
backerundisclosedAug 1, 2025
Series A
OOxford Flow
Robotics and hardware
backer$25MDec 5, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 27 rounds on Recent Funding that name Oxford Science Enterprises. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Oxford Science Enterprises, which is a subset of its real portfolio. API: /api/v1/investors/oxford-science-enterprises (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy